Laureate Education spent the first half of 2026 shifting from cautious reaffirmations to an outright raise of its full-year outlook, and the third-quarter report is where that new confidence has to show up in hard numbers. The quarter captures the September primary intake in Mexico, the most important enrollment event of the year, which management described last quarter as roughly half complete and tracking to plan. Whether that intake landed as cleanly as promised will largely decide whether the raised guidance looks conservative or merely adequate.
Wall Street expects earnings of $0.47 per share on revenue of $477.1 million, up 88% and 19.2% respectively from the $0.25 and $400.2 million posted a year ago. Those growth rates look dramatic, but they run well ahead of the 6% to 7% constant-currency revenue growth management has framed for the full year, which suggests currency translation and timing are likely doing much of the lifting. Investors should focus less on the headline percentage and more on the underlying enrollment and margin trends. The third quarter is also seasonally lighter than the second, when Laureate earned $1.00 per share on $615.9 million in revenue, so a sequential drop is expected rather than alarming.
The guidance comparison is telling. Management now calls for 2026 earnings of $2.04 to $2.10 per share on revenue of $1.92 billion to $1.93 billion, along with adjusted EBITDA of $593 million to $599 million and enrollments of 518,000 to 523,000. Consensus sits at $2.09 per share, near the top of the earnings range, while the $1.92 billion revenue estimate rests at the bottom of the sales range. In other words, analysts are assuming Laureate converts revenue to profit efficiently, partly with help from buybacks. The company repurchased $181 million of stock in the first half and added a fresh $150 million authorization, so a shrinking share count gives EPS a cushion even if operations merely meet plan.
Operationally, Mexico carries the most weight. The narrative improved through the year, with the March intake up 4% and the June adult intake accelerating to 12%. A September result that holds or extends that trend would validate management's view that the sluggish Mexican backdrop has turned. Margins are the second test. Mexico's adjusted EBITDA was down 2% in constant currency through midyear because of startup costs at the new Puebla campus, and management has again said margin gains are weighted toward the back half. The third quarter needs to show that recovery beginning. In Peru, the questions are whether online enrollment keeps scaling and whether the growing online mix continues to dilute revenue per student more than volume gains can offset. Updates on South Lima and Mérida, both slated for 2027, plus any fresh commentary on the USMCA annual review, will shape the longer-term story.
The market has not paid up for the improved tone. Shares are down about 1% since the last report while the S&P 500 gained 4.5%, even as sentiment readings warmed to 28.7% bullish from 18.7% a quarter ago. At $38.96, the stock sits above its 200-day moving average of $35.46 and in the upper half of its post-earnings range, though still roughly 5% shy of the $40.93 high. That combination of better sentiment and lagging price suggests investors want proof before rewarding the guidance raise.
The central issue is simple: did the September intake confirm Mexico's acceleration while Puebla costs began to fade? A solid intake paired with visible margin improvement would keep the raised outlook credible and perhaps leave room for another nudge higher. A soft intake or a further delay in margin recovery would suggest the first-half optimism got ahead of the fundamentals.